Found 60 matching trials
Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q PHASE2 Myelodysplastic syndromes (MDS) prevail in elderly patients and are charact...
Show More Learn More & Join Trial
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy PHASE2 Phase II randomized placebo-controlled study to assess the impact on outcom...
Show More Status
Active Not Recruiting
Location
CHU ANGERS - Maladies du sang
Learn More & Join Trial
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients PHASE2 Severe aplastic anemia (SAA) is a life-threatening blood disease which can ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PHASE3 This is a Phase II/III multicenter study comprising of the double-blind, fo...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Rollover Study to Provide Continued Treatment With Eltrombopag PHASE4 The objective of this study was to provide continued treatment with eltromb...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) PHASE4 This multicenter randomized, open-label study aim to compare the efficacy a...
Show More Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection PHASE2 Primary Objective: To evaluate the efficacy of 6-week Eltrombopag to treat ...
Show More Location
Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease PHASE3 The purpose of this study is to assess the ability of eltrombopag to mainta...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations PHASE2 The purpose of this study is to evaluate if a study drug called eltrombopag...
Show More Location
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Learn More & Join Trial
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia PHASE2 The objective of the study is to estimate the response to eltrombopag based...
Show More Learn More & Join Trial